Literature DB >> 12531337

Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.

Guido Dietrich1, Jean-Francois Viret, Jürgen Hess.   

Abstract

Mycobacterium bovis Bacille Calmette-Guérin (BCG) is one of the most widely used vaccines. Modern techniques in genome manipulation allow the construction of recombinant (r)-BCG strains that can be employed as highly immunogenic vaccines against tuberculosis (TB) with an enhanced safety profile. In addition, the development of novel procedures to cultivate BCG will allow the large-scale production of future BCG-based vaccines.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12531337     DOI： 10.1016/s0264-410x(02)00577-7

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

2.  DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice.

Authors:  Francisco M Teixeira; Henrique C Teixeira; Ana Paula Ferreira; Michele F Rodrigues; Vasco Azevedo; Gilson C Macedo; Sergio C Oliveira
Journal:  Clin Vaccine Immunol       Date:  2006-08

3.  M. tuberculosis H37Rv infection of Chinese rhesus macaques.

Authors:  Jing Zhang; Yan-Qing Ye; Yong Wang; Ping-Zheng Mo; Qiao-Yang Xian; Yan Rao; Rong Bao; Ming Dai; Jun-Yan Liu; Ming Guo; Xin Wang; Zhi-Xiang Huang; Li-Hua Sun; Zhi-Jiao Tang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2010-10-12       Impact factor: 4.147

4.  A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.

Authors:  Jose C Ferraz; Evangelos Stavropoulos; Min Yang; Steve Coade; Clara Espitia; Douglas B Lowrie; M Joseph Colston; Ricardo E Tascon
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  Assessment of diagnostic techniques of urinary tuberculosis.

Authors:  Khaled Ghaleb; Magdy Afifi; Mohamad El-Gohary
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-06-03       Impact factor: 2.576

6.  Laboratory diagnosis of tuberculous meningitis - is there a scope for further improvement?

Authors:  Rajeev Thakur; Renu Goyal; Smita Sarma
Journal:  J Lab Physicians       Date:  2010-01

7.  Construction of a DNA Vaccine Encoding Mtb32C and HBHA Genes of Mycobacterium tuberculosis.

Authors:  Roghayeh Teimourpour; Ali Sadeghian; Zahra Meshkat; Majid Esmaelizad; Mojtaba Sankian; Ahmad-Reza Jabbari
Journal:  Jundishapur J Microbiol       Date:  2015-08-29       Impact factor: 0.747

8.  A Nonsynonymous SNP Catalog of Mycobacterium tuberculosis Virulence Genes and Its Use for Detecting New Potentially Virulent Sublineages.

Authors:  Natalya E Mikheecheva; Marina V Zaychikova; Alexander V Melerzanov; Valery N Danilenko
Journal:  Genome Biol Evol       Date:  2017-04-01       Impact factor: 3.416

9.  A study on the immune response induced by a DNA vaccine encoding Mtb32C-HBHA antigen of Mycobacterium tuberculosis.

Authors:  Roghayeh Teimourpour; Hadi Peeridogaheh; Amir Teimourpour; Mohsen Arzanlou; Zahra Meshkat
Journal:  Iran J Basic Med Sci       Date:  2017-10       Impact factor: 2.699

10.  Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine.

Authors:  Catherine A Cosgrove; Luiz R R Castello-Branco; Tracy Hussell; Amy Sexton; Rafaela Giemza; Richard Phillips; Andrew Williams; George E Griffin; Gordon Dougan; David J M Lewis
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.